The role of oral anticoagulant with direct thrombin inhibition in atrial fibrillation

28 Mar 2024
The role of oral anticoagulant
with direct thrombin
inhibition in atrial fibrillation
Atrial fibrillation was the focus of discussion during a Boehringer Ingelheim-sponsored symposium in conjunction with the Malaysian Heart Rhythm Society Summit 2023. A panel of experts consisting of two Consultant Cardiologists and a Consultant Neurologist had a lively conversation on evidence-based practices in the management of atrial fibrillation. Some of the key points are presented here.

Related MIMS Drugs

Editor's Recommendations